US Patent Issued to Sorbonne Universite, INSERM (Institut National de la Sante et de la Recherche Medicale), Assistance Publique-Hopitaux de Paris on Sept. 30 for "Virus-like particles which can be used in the treatment of allergies" (French Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,625, issued on Sept. 30, was assigned to Sorbonne Universite (Paris), INSERM (Institut National de la Sante et de la Recherche Medicale) (Paris) and Assistance Publique-Hopitaux de Paris (Paris).

"Virus-like particles which can be used in the treatment of allergies" was invented by Bertrand Bellier (Paris) and David Klatzmann (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a virus-like particle comprising an allergen and an immunoregulatory molecule exposed on its surface. The invention also relates to the use of said particle in the treatment of an allergy."

The patent was filed on Oct. 26, 2018, under Application N...